Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 14

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 14
---
 directors to develop a deep knowledge of the business and competitive environment. Staggered terms give the Company’s new directors an opportunity to gain knowledge about the Company’s business from its continuing directors. |

| • | The Board has implemented broad measures to ensure accountability of our directors, including our Corporate Governance Guidelines, Code of Business Conduct and Ethics (the “Code of Conduct”), and annual self-evaluations of the performance of the Board and its committees, which is led by the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee assesses the performance of each current director as part of its consideration of whether to re-nominate to the Board. As a result, the Company benefits from the stability and continuity of a classified Board structure, while retaining meaningful director accountability. |

| Inspire Medical Systems, Inc. |     | 14 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

| CORPORATE GOVERNANCE |

| • | While a classified board structure does not preclude unsolicited acquisition proposals, by eliminating the threat of imminent removal, it allows the Board to maximize the value of a potential acquisition by giving the Company time and bargaining leverage to evaluate and negotiate the adequacy and fairness of any takeover proposal and to consider alternatives, including the continued operation of the Company’s business. |

PLURALITY Voting Standard for Director Elections The Company’s current plurality voting standard yields a definitive result in a simple, efficient and transparent manner, which has historically been effective in electing strong, independent directors to our Board. Further, we believe that under the current plurality voting standard, stockholders have a meaningful opportunity to express disapproval with corporate policies, strategy, or director candidates through the use of withhold votes. Our Corporate Governance Guidelines provide that in an uncontested election of directors, any nominee for director who does not receive a majority of the votes cast for his or her election shall offer to resign from the Board. The Nominating and Corporate Governance Committee shall promptly consider the resignation offer and recommend to the full Board whether to accept it. The Board will act on the Nominating and Corporate Governance Committee’s recommendation within 90 days following the certification of the stockholder vote by the inspector of elections, and will disclose its decision and the reasons for rejecting the offer, if applicable, in a current report on Form 8-K. Any director who tenders his or her offer to resign from the Board pursuant to the Corporate Governance Guidelines may not participate in the Nominating and Corporate Governance Committee or Board deliberations regarding